Community pharmacy input to Vac4covid
Interview and article by Christine Clark. Community pharmacies are at the heart of their communities and can contribute to the Vac4covid study by signposting patients to the website,… read more.
Interview and article by Christine Clark. Community pharmacies are at the heart of their communities and can contribute to the Vac4covid study by signposting patients to the website,… read more.
Interview and article by Christine Clark. Gavin Dobson, Clinical Trials Pharmacist at MEMO Research explains the practical details of the Vac4covid study. The Vac4covid study will recruit at… read more.
Children and young adults who receive CAR T-cell therapy for the most common childhood cancer – acute lymphoblastic leukemia – suffer remarkably fewer relapses and are far more… read more.
Interview and article by Christine Clark. The Vac4covid study has been designed to provide important data about the safety and effectiveness of covid-19 vaccines. IMI interviewed Mr Gavin… read more.
Infants born by cesarean section have a relatively meager array of bacteria in the gut. But by the age of three to five years they are broadly in… read more.
Health Canada issued a Notice of Compliance for Taltz (ixekizumab), from Eli Lilly, injection, 80 mg/mL, for the treatment of pediatric patients from six to less than 18… read more.
ASHP (American Society of Health-System Pharmacists) today announced the publication of two landmark reports that articulate a futuristic vision for pharmacy practice, including expanded roles for the pharmacy enterprise… read more.
AbbVie announced that the FDA has extended the review period for the supplemental New Drug Application (sNDA) for upadacitinib in the treatment of adult patients with active psoriatic… read more.
Article by Bruce Sylvester. Treatment of common pneumonia in children six months to 10 years-old with a five-day course of high-dose amoxicillin is as effective as 10-day treatment,… read more.
Article written by Gary Finnegan. The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended six medicines for approval at its February 2021 meeting:
Roche announced that the New England Journal of Medicine has published Evrysdi (risdiplam) data from the dose finding Part 1 of the pivotal FIREFISH study in infants with… read more.
The centre is part of the German Federal Institute for Risk Assessment (BfR). With the help of microscopy and artificial intelligence, the “E-Morph” test reliably identifies substances that… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.